Table 1.

Case characteristics, definition, and related criteria for acute hemoglobinemia or hemoglobinuria








Acute hemoglobinemia or hemoglobinuria case definition (and related) criteria
Case no.
Age, y
Sex
FDA received initial report
Indication for anti-D IGIV
Dose, μg/kg
Acute*
Hemoglobinemia
Hemoglobinuria
MD assessment§
1   12   M   May 1999   ITP   50     Yes   Yes  
2   85   M   Aug 1999   ITP   50   Yes   Yes   Yes   Yes  
3   75   M   Aug 2002   ITP   48   Yes    Yes   Yes  
4   25   F   Sep 2003   ITP   50     Yes   Yes  
5   71   F   Sep 2004   ITP   75   Yes    Yes   Yes  
6
 
67
 
M
 
Oct 2004
 
ITP
 
51
 
Yes
 

 
Yes
 
Yes
 







Acute hemoglobinemia or hemoglobinuria case definition (and related) criteria
Case no.
Age, y
Sex
FDA received initial report
Indication for anti-D IGIV
Dose, μg/kg
Acute*
Hemoglobinemia
Hemoglobinuria
MD assessment§
1   12   M   May 1999   ITP   50     Yes   Yes  
2   85   M   Aug 1999   ITP   50   Yes   Yes   Yes   Yes  
3   75   M   Aug 2002   ITP   48   Yes    Yes   Yes  
4   25   F   Sep 2003   ITP   50     Yes   Yes  
5   71   F   Sep 2004   ITP   75   Yes    Yes   Yes  
6
 
67
 
M
 
Oct 2004
 
ITP
 
51
 
Yes
 

 
Yes
 
Yes
 

— indicates no information available.

*

Signs or symptoms within 4 hours of anti-D IGIV administration.

Increased serum hemoglobin level or anecdotal report of “visibly red serum” (or similar terms).

Positive urine reagent strip test for blood and urinary sediment with fewer RBCs than would correspond to degree of positivity of reagent strip or anecdotal report of “tea-colored urine” (or similar terms).

§

Attending or consulting physician assessment that hemoglobinemia or hemoglobinuria occurred.

Exact time of onset indeterminate due to incomplete medical history.

Relevant laboratory test results not available or not optimally timed.

Close Modal

or Create an Account

Close Modal
Close Modal